Revive Therapeutics Ltd
Change company Symbol lookup
Select an option...
RVVTF Revive Therapeutics Ltd
EPR EPR Properties
ID Parts Id Inc
EGAN eGain Corp
SMED Sharps Compliance Corp
CUB Cubic Corp
CHGG Chegg Inc
RIO Rio Tinto PLC
PTOS P2 Solar Inc
LUV Southwest Airlines Co

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

Day's Change
0.0058 (1.49%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 355,864 shares is on pace to be much greater than RVVTF's 10-day average volume of 878,736 shares.

  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    10:25a ET 04/14/21
  • Last (size)
  • 52-Wk Range
    0.0734 - 0.72
  • (04/20/20 - 12/14/20)
  • 163.5%
  • Market Cap
  • Shares Outstanding
  • -0.06
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 1.75
  • --

Latest News

April 14, 2021
8:30 am ET
PR Newswire
April 12, 2021
2:49 pm ET
Globe Newswire
April 08, 2021
6:00 pm ET
Globe Newswire
March 24, 2021
3:13 pm ET
Globe Newswire
8:27 am ET
Globe Newswire
March 19, 2021
7:30 am ET
Globe Newswire
March 17, 2021
8:50 am ET
PR Newswire
March 09, 2021
10:55 am ET
PR Newswire
March 02, 2021
8:30 am ET
PR Newswire
February 26, 2021
9:50 am ET
Globe Newswire
8:33 am ET
Globe Newswire
February 23, 2021
10:16 am ET
February 17, 2021
9:00 am ET
Globe Newswire
February 12, 2021
9:32 pm ET
Globe Newswire
February 11, 2021
9:01 am ET
PR Newswire
7:28 am ET
Globe Newswire
February 09, 2021
5:00 pm ET
Globe Newswire
February 08, 2021
5:38 pm ET
Globe Newswire
January 22, 2021
11:05 am ET
Globe Newswire
Go to all current & historical news


There are no calendar events for RVVTF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.